US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.3900
  • +0.1000+7.75%
Close Nov 5 16:00 ET
2.91MMarket Cap-80P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
Gross profit
0
0
Operating expense
-73.37%809.67K
-71.29%903.54K
157.24%9.43M
-9.87%1.16M
70.67%2.08M
547.74%3.04M
356.50%3.15M
232.27%3.67M
179.51%1.29M
430.61%1.22M
Selling and administrative expenses
-38.33%459.22K
18.14%657.91K
20.84%2.52M
34.21%712.93K
12.49%506.04K
64.85%744.62K
-14.73%556.89K
104.29%2.09M
24.71%531.21K
95.77%449.87K
-General and administrative expense
-38.33%459.22K
18.14%657.91K
20.84%2.52M
34.21%712.93K
12.49%506.04K
64.85%744.62K
-14.73%556.89K
104.29%2.09M
24.71%531.21K
95.77%449.87K
Research and development costs
-84.73%350.44K
-90.52%245.63K
337.40%6.91M
-40.85%447.08K
104.68%1.57M
12,941.20%2.3M
7,017.16%2.59M
1,824.94%1.58M
2,089.20%755.89K
--769.41K
Operating profit
73.37%-809.67K
71.29%-903.54K
-157.24%-9.43M
9.87%-1.16M
-70.67%-2.08M
-547.74%-3.04M
-356.50%-3.15M
-232.27%-3.67M
-179.51%-1.29M
-430.61%-1.22M
Net non-operating interest income expense
3,439.02%15.15K
-54.14%255
100.26%1.87K
100.05%349
536
428
556
9.12%-731.71K
-4,859.09%-731.71K
0
Non-operating interest income
3,439.02%15.15K
-54.14%255
--1.87K
--349
--536
--428
--556
--0
--0
--0
Total other finance cost
----
----
----
----
----
----
----
--731.71K
----
----
Other net income (expense)
-99.15%10.79K
106.63%37.31K
-83.60%477.7K
-390.23K
160.65K
1.27M
-562.92K
878.91%2.91M
Gain on sale of security
-99.15%10.79K
106.63%37.31K
-69.35%892.69K
--24.76K
--160.65K
--1.27M
---562.92K
--2.91M
----
----
Special income (charges)
----
----
---414.99K
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
--414.99K
----
----
----
----
----
----
----
Income before tax
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Income tax
Net income
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Net income continuous Operations
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Minority interest income
Net income attributable to the parent company
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Basic earnings per share
87.14%-0.67
97.63%-1.31
-9.18%-34.01
-112.10%-2.9011
82.72%-4.88
52.11%-5.21
-228.57%-55.2
62.92%-31.15
681.62%23.97
30.78%-28.24
Diluted earnings per share
87.14%-0.67
97.63%-1.31
-9.18%-34.01
-112.10%-2.9011
82.72%-4.88
52.11%-5.21
-228.57%-55.2
62.92%-31.15
681.62%23.97
30.78%-28.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 00
Gross profit 00
Operating expense -73.37%809.67K-71.29%903.54K157.24%9.43M-9.87%1.16M70.67%2.08M547.74%3.04M356.50%3.15M232.27%3.67M179.51%1.29M430.61%1.22M
Selling and administrative expenses -38.33%459.22K18.14%657.91K20.84%2.52M34.21%712.93K12.49%506.04K64.85%744.62K-14.73%556.89K104.29%2.09M24.71%531.21K95.77%449.87K
-General and administrative expense -38.33%459.22K18.14%657.91K20.84%2.52M34.21%712.93K12.49%506.04K64.85%744.62K-14.73%556.89K104.29%2.09M24.71%531.21K95.77%449.87K
Research and development costs -84.73%350.44K-90.52%245.63K337.40%6.91M-40.85%447.08K104.68%1.57M12,941.20%2.3M7,017.16%2.59M1,824.94%1.58M2,089.20%755.89K--769.41K
Operating profit 73.37%-809.67K71.29%-903.54K-157.24%-9.43M9.87%-1.16M-70.67%-2.08M-547.74%-3.04M-356.50%-3.15M-232.27%-3.67M-179.51%-1.29M-430.61%-1.22M
Net non-operating interest income expense 3,439.02%15.15K-54.14%255100.26%1.87K100.05%3495364285569.12%-731.71K-4,859.09%-731.71K0
Non-operating interest income 3,439.02%15.15K-54.14%255--1.87K--349--536--428--556--0--0--0
Total other finance cost ------------------------------731.71K--------
Other net income (expense) -99.15%10.79K106.63%37.31K-83.60%477.7K-390.23K160.65K1.27M-562.92K878.91%2.91M
Gain on sale of security -99.15%10.79K106.63%37.31K-69.35%892.69K--24.76K--160.65K--1.27M---562.92K--2.91M--------
Special income (charges) -----------414.99K------------------0--------
-Less:Other special charges ----------414.99K----------------------------
Income before tax 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Income tax
Net income 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Net income continuous Operations 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Minority interest income
Net income attributable to the parent company 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Basic earnings per share 87.14%-0.6797.63%-1.31-9.18%-34.01-112.10%-2.901182.72%-4.8852.11%-5.21-228.57%-55.262.92%-31.15681.62%23.9730.78%-28.24
Diluted earnings per share 87.14%-0.6797.63%-1.31-9.18%-34.01-112.10%-2.901182.72%-4.8852.11%-5.21-228.57%-55.262.92%-31.15681.62%23.9730.78%-28.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data